- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2020–2025 · research · R50
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironment
Shuqiang Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Studies of mutant-selective allosteric inhibitors of EGFR for non-small cell lung cancer
Tyler Steven Beyett · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · grant · PCRP
Crosstalk between Notch signaling and lineage-determining transcriptional factors drives neuroendocrine differentiation in advanced prostate cancer
Sheng-Yu Ku · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2026 · research · R01
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Remodeling mitochondrial cristae to rescue bioenergetic defects in mitochondrial disease
Beste Mutlu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing the LINE-1 Retrotransposition-Replication Conflict
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · career development · K22
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma
Catherine Marinac · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · research · R01
The role of NCOA4-mediated ferritinophagy in iron homeostasis and ferroptosis
Joseph D Mancias · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R37
Molecular mechanisms underlying lineage plasticity in prostate cancer
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · research · R01
Immunologic mechanisms that prevent autoimmunity
Harvey Cantor · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · program · P50
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
Cesar M Castro · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · career development · K99
Contributions of tumor molecular subtypes to prostate cancer racial disparities
Kevin Hughes Kensler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India
Shoba Ramanadhan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Identifying Combination Therapies in Ovarian Tumors using High Throughput Dynamic BH3 Profiling
Kelley Mcqueeney · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2021 · research · R03
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Defining IKZF1/IKAROS as an oncogene and therapeutic target in MLL-r AML
Jevon Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R37
Liquid biopsy approaches to inform osteosarcoma prognosis and tumor evolution
Brian Crompton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020 · career development · K08
Targeting molecular vulnerabilities of ovarian cancer
Sarah James Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · grant · DP5
Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
Sarah James Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
Cloud Peter Paweletz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · grant · DP5
Dissecting the interaction between DNA damage repair defects and the tumor microenvironment
Sarah James Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · grant · PCRP
The role of the paralogs CBP and p300 in androgen receptor function and prostate cancer
Alok Tewari · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2025 · research · R01
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
Martin E Hemler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · grant · KCRP
Combining Locally Administered Ipilimumab with a Personalized Neoantigen Cancer Vaccine to Improve T-Cell Priming and Antitumor Immunity in High-Risk Renal Cell Carcinoma
Toni Choueiri · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2020–2027 · research · R35
The role of clonal hematopoiesis in the development and therapy of myeloid malignancies
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · UE5
Academic Career Skills for Junior Faculty Researchers
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · research · R21
Curated prostate cancer data for novel and reproducible prognostic modeling
James Christopher Costello · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
Deep clinical trajectory modeling to optimize accrual to cancer clinical trials
Kenneth L Kehl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Next Generation Computational Tools for Functional Genomics
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India
Shoba Ramanadhan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · research · R21
Development of an OPTogenetic InteractoMics Assay (OPTIMA)
Michael A Calderwood · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · career development · K01
Mesenchymal regulation of fetal intestinal development and adult regeneration
Neil Mccarthy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · fellowship · F32
Remodeling mitochondrial cristae to rescue bioenergetic defects in mitochondrial disease
Beste Mutlu · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R37
Molecular mechanisms underlying lineage plasticity in prostate cancer
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
The role of NCOA4-mediated ferritinophagy in iron homeostasis and ferroptosis
Joseph D Mancias · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · program · P01
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage
Matthew J. Lang · Dana-Farber Cancer Institute · funded by National Institutes of Health
